Works matching IS 13479032 AND DT 2024 AND VI 115 AND IP 12
Results: 25
A combination of lymphatic drug delivery of anti‐CTLA‐4 antibody and local radiotherapy for solid‐tumor treatment.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4021, doi. 10.1111/cas.16369
- By:
- Publication type:
- Article
In this issue: Volume 115, Issue 12, December 2024.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3835, doi. 10.1111/cas.16411
- Publication type:
- Article
Reviewers The publication of invaluable papers in Cancer Science depends on the prompt, careful review of submitted manuscripts. We would like to thank the following experts for reviewing manuscripts submitted between October 1, 2023 to September 30, 2024
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4074, doi. 10.1111/cas.16399
- Publication type:
- Article
Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3952, doi. 10.1111/cas.16367
- By:
- Publication type:
- Article
The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐PD‐1 antibody and paclitaxel.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4008, doi. 10.1111/cas.16366
- By:
- Publication type:
- Article
Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4054, doi. 10.1111/cas.16365
- By:
- Publication type:
- Article
Benign polymorphisms in the BRCA genes with linkage disequilibrium is associated with cancer characteristics.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3973, doi. 10.1111/cas.16364
- By:
- Publication type:
- Article
Population pharmacokinetic model of ABL001/CTX‐009 (anti‐VEGF/DLL4) in adult cancer patients with solid tumor.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3943, doi. 10.1111/cas.16363
- By:
- Publication type:
- Article
CX3CR1<sup>+</sup>CD8<sup>+</sup> T cells: Key players in antitumor immunity.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3838, doi. 10.1111/cas.16359
- By:
- Publication type:
- Article
Correction to "Expression of concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance"
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4081, doi. 10.1111/cas.16357
- Publication type:
- Article
SNRPB2 promotes triple‐negative breast cancer progression by controlling alternative splicing of MDM4 pre‐mRNA.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3915, doi. 10.1111/cas.16356
- By:
- Publication type:
- Article
Specific cancer types and prognosis in patients with variations in the KEAP1‐NRF2 system: A retrospective cohort study.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4034, doi. 10.1111/cas.16355
- By:
- Publication type:
- Article
Identification of sequence polymorphism in the D‐loop region of mitochondrial DNA as a risk factor for breast cancer.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4064, doi. 10.1111/cas.16353
- By:
- Publication type:
- Article
BBOX1‐AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial–mesenchymal transition process.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3875, doi. 10.1111/cas.16350
- By:
- Publication type:
- Article
Selective killing of castration‐resistant prostate cancer cells by formycin A via the ATF4–CHOP axis.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3997, doi. 10.1111/cas.16349
- By:
- Publication type:
- Article
Host ANGPTL2 establishes an immunosuppressive tumor microenvironment and resistance to immune checkpoint therapy.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3846, doi. 10.1111/cas.16348
- By:
- Publication type:
- Article
RETRACTION: Zebularine Enhances Apoptosis of Human Osteosarcoma Cells by Suppressing Methylation of ARHI.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4080, doi. 10.1111/cas.16346
- Publication type:
- Article
Decreased PU.1 expression in mature B cells induces lymphomagenesis.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3890, doi. 10.1111/cas.16344
- By:
- Publication type:
- Article
Leveraging non‐coding regions to guarantee the accuracy of small‐sized panel‐based tumor mutational burden estimates.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 4045, doi. 10.1111/cas.16342
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3831, doi. 10.1111/cas.15868
- Publication type:
- Article
Loss of USP10 promotes hepatocellular carcinoma proliferation by regulating the serine synthesis pathway through inhibition of LKB1 activity.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3902, doi. 10.1111/cas.16336
- By:
- Publication type:
- Article
Anti‐tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3986, doi. 10.1111/cas.16335
- By:
- Publication type:
- Article
Tumor immune microenvironment dynamics and outcomes of prognosis in non‐muscle‐invasive bladder cancer.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3963, doi. 10.1111/cas.16333
- By:
- Publication type:
- Article
Dynamic single‐cell sequencing unveils the tumor microenvironment evolution of gastric cancer abdominal wall metastases during radiotherapy.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3859, doi. 10.1111/cas.16308
- By:
- Publication type:
- Article
Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors.
- Published in:
- Cancer Science, 2024, v. 115, n. 12, p. 3928, doi. 10.1111/cas.16339
- By:
- Publication type:
- Article